CompletedPhase 4NCT02371941

Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis

Studying NON RARE IN EUROPE: Eosinophilic esophagitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Tennessee
Principal Investigator
Jay A Lieberman, MD
The University of Tennessee Health Science Center
Intervention
oral cromolyn sodium(drug)
Enrollment
16 enrolled
Eligibility
2-18 years · All sexes
Timeline
20142017

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02371941 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Eosinophilic esophagitis

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Eosinophilic esophagitis

← Back to all trials